Prognostic Value of SYNTAX Score II in Patients with Acute Coronary Syndromes Referred for Invasive Management: A Subanalysis from the SPUM and COMFORTABLE AMI Cohorts

Table 4

Clinical outcomes at 1 year stratified by tertiles of SYNTAX score II.


Outcomes at one year	SxSII_Low≤21.5	SxSII_Mid 21.5–30.6	SxSII_High ≥30.6	value
Outcomes at one year				value

All-cause mortality	2 (0.8)	3 (1.2)	23 (9.4)	<0.001	28 (3.8)
Cardiovascular death	1 (0.4)	3 (1.2)	17 (7.0)	<0.001	21 (2.8)
Noncardiovascular death	1 (0.4)	0 (0.0)	6 (2.4)	0.007	7 (0.9)
Cerebrovascular event	0 (0.0)	1 (0.4)	3 (1.2)	0.134	4 (0.5)
Myocardial infarction	1 (0.4)	9 (3.7)	10 (4.1)	0.011	20 (2.7)
Clinically driven revascularization	4 (1.6)	16 (6.5)	21 (8.6)	0.002	41 (5.6)
Target vessel revascularization	2 (1.7)	13(5.3)	13 (5.3)	0.011	28 (3.8)
Any revascularization	4 (1.6)	18(7.3)	21 (8.6)	0.002	43 (5.8)
Restenotic lesion revascularisation	3 (1.7%)	2 (1.2%)	9 (1.8%)	0.03	14 (1.9)
Any stent thrombosis	2 (1.1%)	0 (0%)	3 (1.9%)	0.59	5 (0.6)
Early thrombosis	1 (0.6%)	0 (0%)	2 (1.3%)	0.50	3 (0.4)
Late thrombosis	1 (0.6%)	0 (0%)	1 (0.6%)	0.77	2 (0.2)
MACE	5 (2.0)	20 (8.2)	35 (14.3)	<0.001	60 (7.4)
MACCE	6 (2.4)	21 (8.6)	43 (17.6)	<0.001	70(9.5)

MACE, major adverse cardiac events; MACCE, major adverse cardiac and cerebrovascular events.